Genethon appoints biopharma industry expert Frédéric Revah as Chief Executive
…
(read more)Gene therapy: Production of the first batch of HIV-derived vectors in Europe for use in a human clinical trial
Genethon, the laboratory created and funded by the AFM (French Association against Myopathies) using donations from Téléthon, today announced that it has produced, controlled and released a batch of lentiviral vectors derived from the human immunodeficiency (HIV) virus for a gene therapy trial in humans in a rare immune deficiency. The…
(read more)Neuromuscular diseases: A pharmacological therapeutic approach for certain sarcoglycanopathies
…
(read more)